AI stethoscope could spot hidden heart disease in minutes
NCT ID NCT07147725
First seen Nov 01, 2025
Summary
This study will test whether an AI-powered smart stethoscope can accurately detect pulmonary hypertension and other cardiovascular diseases. Researchers will enroll 1,000 adults already scheduled for routine echocardiography. Each participant will have a short, non-invasive recording with the stethoscope, and the AI's findings will be compared to the standard ultrasound results.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PULMONARY HYPERTENSION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Imperial College Healthcare NHS Trust
London, United Kingdom
Contact Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
AI-powered smart stethoscope (device)
What this could lead to
If successful, this could lead to a simple, non-invasive way to detect pulmonary hypertension and other heart conditions earlier, using just a stethoscope and AI.
What could go wrong
This is an early validation study, not a treatment trial. The AI may not perform as well in real-world settings as in lab tests, and it will need further studies before it can be used in clinics.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.